Rapid bedside testing Position iAssay as a time and cost-saving, handheld point-of-care solution that consolidates tests from multiple devices into a single device, enabling immediate results at the patient site to drive faster clinical decisions and revenue opportunities for partner clinics and home health providers.

Open platform value Emphasize the device’s open platform and app ecosystem to healthcare organizations, enabling custom content partnerships, device integrations, and scalable diagnostic workflows that can be sold as modular solutions to expand market reach.

Data integration potential Highlight HIPAA-compliant data aggregation and cloud population into EMRs as a differentiator for health systems seeking streamlined data capture, improving billing accuracy, population health analytics, and IT interoperability for new contracts.

Home health expansion Leverage evidence of home-based and remote testing capability to pursue partnerships with home health agencies, urgent care networks, and telehealth platforms seeking to reduce trips to central labs and improve patient engagement.

Strategic partnerships Target collaborations with Dx content partners and diagnostics ecosystems to accelerate device adoption, co-develop bundled offerings, and access funded programs, leveraging past partnerships with Fio Corporation and Helios Bioelectronics as proof points.